| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a629ac75687bb59dfdc4fcc72a0f5935 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c55a47fafe6f77e2db388f7db1bdcc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f739b4a84f33d3e02d77d87ffe62038d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c450935999e84628681f1300ed31e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e024b042dc23e006a4a4611d708f4924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_775930e62b2ab86101f9b61791ebede8 |
| publicationDate |
2021-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021050688-A1 |
| titleOfInvention |
Compounds and uses thereof |
| abstract |
The present invention relates to compositions and methods for the treatment of HA01 -associated disorders, such as primary hyperoxaluria 1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427558-B1 |
| priorityDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |